Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2025-12-26 @ 12:15 PM
NCT ID:
NCT03595800
Eligibility Criteria:
Inclusion Criteria:
* Patients with hematological malignancy
* Age\<55 years
* HCT-CI score ≥ 3 or non-eligible for myeloablative regimen
* Patients without a matched related donor
* Patients eligible for an allogeneic HSCT from an alternative donor
* Able to comply with the protocol
* Written informed consent
* Patient affiliated to the national "Social Security" regimen or beneficiary of this regimen
Exclusion Criteria:
* Clinical or biological contraindication to allogeneic HSCT
* Pregnant or breast-feeding women.
* Patient considered socially or psychologically unable to comply with the treatment and the required medical follow-up.
* Severe concomitant disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT03595800
Study Brief:
Protocol Section:
NCT03595800